March 30, 2026
A health checkup at 70 is a different exercise than a checkup at 40. The probabilities have shifted. The questions have changed. Some screening tests that mattered in middle age have become low-yield, while new categories — cognitive baseline, sarcopenia, fall risk, atrial fibrillation surveillance — have moved to the front of the line. Done well, a senior screening is not a longer version of a younger person's screening; it is a different conversation.
Taiwan has quietly become a destination for senior screenings because the country combines unhurried hospital workflows, English-speaking coordinators, and a willingness to actually sit with older patients and discuss what the numbers mean. This guide walks through what changes at 65+, which tests carry their weight, and how to plan a trip that respects the body of someone who has already lived seven decades. For the broader booking and logistics framework, our step-by-step guide to full-body MRI health exams is the right starting reference.
The first thing to understand: cardiovascular disease is still the number-one cause of death after 65. It does not become less relevant — if anything, the absolute risk per year is higher than at any earlier life stage. So the cardiovascular core of a screening (lipid panel, blood pressure profiling, ECG, often a coronary calcium score and carotid ultrasound) remains central. What changes is that several new categories rise to equal or greater importance: cognitive baseline, sarcopenia and bone health, fall risk, and atrial fibrillation surveillance.
The second thing to understand: cancer screening recommendations narrow with age. The U.S. Preventive Services Task Force (USPSTF) recommends stopping routine mammography at 75, colonoscopy at 75 (with shared decision-making 76-85), and cervical screening at 65 in low-risk women. This is not because cancer becomes less likely — it is because the lead time required for a screen-detected cancer to harm someone shortens, while the harms of testing (anxiety, biopsy complications, overtreatment of indolent disease) accumulate. A good senior screening program in Taiwan should know these recommendations and have a real conversation about them, not simply add every test available.
The third change is functional. Strength, balance, gait speed, and grip strength matter as predictors of mortality and independence. A senior screening that ignores function in favor of more imaging has missed the point.
| Age band | Core priorities | Add or emphasize | Often de-emphasize |
|---|---|---|---|
| 65-69 | Cardiovascular full panel, calcium score, colonoscopy, mammography, DEXA bone density | Cognitive baseline (MoCA), AFib screening (ECG), grip strength | Cervical screening if prior negatives are documented |
| 70-74 | Cardiovascular, DEXA, AFib surveillance, gait/balance assessment | Hippocampal MRI if dementia family history, ABI for peripheral arterial disease, vision and hearing | Aggressive PSA screening (shared decision) |
| 75-79 | Cardiovascular, sarcopenia (DEXA whole-body composition), fall-risk panel, medication review | Cognitive screening annual, ambulatory ECG monitor for occult AFib | Routine mammography and colonoscopy (USPSTF cutoffs — discuss individually) |
| 80+ | Function-first: gait speed, falls, cognition, medication review, nutrition | Targeted tests only when results would change management | Most population-based cancer screening unless life expectancy > 10 years and patient prefers |
One of the most useful things a 65- or 70-year-old can do is establish a cognitive baseline. Not because something is wrong — but because if something becomes wrong five years later, having a documented baseline turns "is this normal aging?" from an unanswerable question into a measurable comparison. The two standard interview-based tools take about 30 minutes:
For patients with a strong family history of Alzheimer's disease or Parkinson's disease, a baseline brain MRI with hippocampal volumetry adds a quantitative anchor. Hippocampal atrophy is one of the earliest structural signatures of Alzheimer's pathology, and modern post-processing software (FreeSurfer, NeuroQuant) returns numerical volumes that can be re-measured years later. Emerging biomarkers — APOE genotype, plasma p-tau 217 — are increasingly available, though the clinical utility for an asymptomatic person is still being defined and the conversation should be cautious. A blood test that suggests elevated risk but offers no actionable intervention is a real psychological event, and patients deserve full counseling before, not after, the result.
| Tool | Time | Strength | Limitation |
|---|---|---|---|
| MMSE | 10-15 min | Widely validated, decades of normative data | Insensitive to mild impairment, ceiling effect in educated patients |
| MoCA | 15-20 min | More sensitive to MCI, executive function coverage | Education adjustment needed; multiple language versions |
| Hippocampal MRI volumetry | 30-45 min scan | Quantitative, repeatable, structural baseline | Cost, finds incidental lesions, no intervention if mild atrophy |
| APOE genotype / plasma p-tau | Blood draw | Risk stratification, research-grade signals | Limited actionability for asymptomatic patients; counseling required |
This is where honest conversations matter most. The USPSTF, after weighing benefits and harms across thousands of trial participants, has set explicit upper age limits for several screening tests:
The reason recommendations shift is not philosophical — it is mathematical. Screen-detected cancers typically take 5-10 years to harm an unscreened person. If the patient's expected remaining life is shorter than that lead time, the chance the test prevents a death is small while the chance it causes a complication or false-positive cascade is unchanged. A good senior program in Taiwan does not pretend this calculation does not exist. It walks the patient through their personal numbers, including a frank estimate of life expectancy, and lets them choose. Some patients will say "I want every test anyway, for peace of mind"; that is a legitimate choice. Others will say "If it isn't likely to extend my life, skip it"; that is also legitimate. The wrong answer is to silently default to maximalism and bill for it.
Dual-energy X-ray absorptiometry (DEXA) is a 15-minute, low-dose scan that produces two numbers that matter enormously after 65: bone mineral density T-score and whole-body composition (lean mass, fat mass, regional distribution). Together they describe the most important physical risks an older adult faces: fractures from osteoporosis and falls and frailty from sarcopenia (age-related muscle loss).
A T-score of -2.5 or lower at the hip or spine defines osteoporosis and roughly doubles fracture risk per standard deviation below normal. Sarcopenia is harder to define by single threshold but appendicular lean mass index below 7.0 kg/m² in men or 5.4 kg/m² in women, combined with low grip strength or slow gait speed, identifies the patients at highest risk for falls, hospitalization, and loss of independence. Once identified, both conditions are partially reversible: resistance training and protein intake (1.2-1.6 g/kg/day) for sarcopenia; calcium, vitamin D, weight-bearing exercise, and pharmacotherapy (bisphosphonates, denosumab) for osteoporosis. The point of the scan is not the number — it is the intervention the number unlocks.
Cardiovascular workup remains the highest-yield part of a senior screening. The classics still apply: lipid panel, blood pressure, ECG, echo if indicated, and a coronary calcium score (CT-based, no contrast, ~5 minutes) which retains value into the 70s for refining risk and guiding statin or antiplatelet decisions. Three additions deserve attention at 65+:
For broader context on how preventive cardiology works in Taiwan compared with U.S. annual physicals, see our piece on preventive health gaps in the U.S. and how Taiwan fills the void.
Standard senior screening packages often skip vision and hearing — a curious omission, since both are first-order risk factors for falls and cognitive decline. Uncorrected vision impairment increases fall risk roughly twofold; uncorrected hearing loss is now established as one of the largest modifiable risk factors for dementia (a 2024 Lancet Commission update placed it among the top contributors). Adding a refraction check, intraocular pressure measurement (glaucoma), and macular OCT for age-related macular degeneration takes 30-45 minutes. A pure-tone audiogram takes 20 minutes. Both can usually be added to a Taiwan screening day with a small fee. The intervention — glasses, hearing aids, cataract surgery — is straightforward, and the downstream benefit (fewer falls, slower cognitive decline, better social engagement) is large.
A long-haul flight is harder at 70 than at 40. Realistic planning looks like this:
Beitou's sulfur springs are one of the things that make Taiwan distinctive as a wellness destination, and they pair naturally with a screening trip. For older adults, a few real cautions apply:
For a fuller view of why post-screening recovery in Taiwan works so well, our piece on why Americans find true wellness recovery in Taiwan covers the pacing in more depth.
Older patients often take 5-10 chronic medications, and any reasonable screening review starts with a complete reconciled list. Bring the following, ideally printed:
The Taiwan physician will often spot interactions or duplications that the home physician has not addressed — not because home physicians are inattentive but because polypharmacy in an older patient is genuinely difficult to keep optimized, and a fresh set of eyes finds things. Common discoveries: anticholinergic burden too high (raising fall and cognitive risk), proton pump inhibitor still being prescribed years past its indication, two beta blockers from two specialists, sleep medications that should taper. Ask for the recommendations to be written in a format you can take to your home physician.
If you are arranging a screening trip for an aging parent rather than for yourself, a different layer of preparation matters:
Persona 1: Margaret, 70, retired teacher, no health complaints. Margaret has never had a cardiac event, her family history is unremarkable, and her U.S. annual physicals have always been "normal." She wants a baseline that is more thorough than what her primary care offers and to have a single document she can keep. The right package: full cardiovascular workup with calcium score, low-dose CT chest (former smoker), mammogram (last one was three years ago), colonoscopy (due), DEXA, MoCA cognitive baseline, full labs. No brain MRI — no family history, no symptoms. Trip length: 7 days.
Persona 2: David, 75, mother died of Alzheimer's at 82. David is sharp, still working part-time as a consultant, and his real concern is not his heart — it is his head. The right package: standard cardiovascular workup, DEXA, plus a baseline brain MRI with hippocampal volumetry, MoCA documented as a quantitative baseline, and a discussion (with full counseling) about whether plasma p-tau or APOE testing is right for him. The Taiwan team should be ready to coordinate follow-up brain MRI in 24-36 months for trend comparison. Trip length: 8 days, including a meeting with neurology to walk through findings.
Persona 3: Dr. Robert Chen, 68, retired physician on annual cycle. Robert has been doing thorough screening every year for 15 years and knows the workflow as well as the staff. He wants the high-end imaging (full-body MRI, coronary CT angiography), labs at the depth his cardiologist friend back home cannot order through insurance, and a willingness to discuss findings as a colleague rather than a patient. The Taiwan team's job here is to be substantive — to push back if he is over-screening himself, to add cognitive testing he may not have on his own list, and to write a report his home physicians can act on. Trip length: 5 days because he is efficient and travels light.
Senior screening is not about doing more tests — it is about doing the right tests, with someone willing to interpret them honestly in the context of a longer life already lived. Taiwan's strength is in unhurried clinics, English-capable coordinators, and physicians comfortable with the long-form conversation that any 65+ checkup deserves. New Dawn Health's role is to help match the right center, the right package, and the right pace to the person traveling. For seniors and the families helping them plan, the goal is the same as ever: clarity, then good years.
Selectively, yes. Function-focused assessments — gait, balance, cognition, medication review, nutrition — remain highly valuable because they directly drive interventions that preserve independence. Most population-based cancer screenings are de-emphasized after 80 because the lead time required for a screen-detected cancer to harm someone often exceeds remaining life expectancy. The right question is "will this test change what we do?" If yes, do it. If not, skip it.
Generally yes, especially if you are 65+. The point of an asymptomatic cognitive baseline (MoCA, often 15-20 minutes) is not to detect a problem today — it is to give you and your future physicians a documented reference point if a question arises in 3-5 years. Without a baseline, "is this normal aging or early decline?" is much harder to answer.
Yes, MRI is safe — it uses no ionizing radiation. The practical considerations are different: a person with MCI may need a companion in the prep room, clearer instructions, possibly mild oral anxiolytic if claustrophobic, and patient staff who can repeat directions. Most major Taiwan centers handle this routinely. Hippocampal volumetry is especially useful in this group because it produces quantitative numbers that can be re-measured over time.
Not strictly required, but strongly recommended for anyone over 75, anyone with any mobility or cognitive concerns, and anyone making the trip for the first time. The companion does not need medical training — a spouse, adult child, or close friend is sufficient. They help with logistics on the days you are tired, hold the medication list, and provide a second set of ears for the results conversation.
A U.S. annual physical at 70 is typically 20-30 minutes with a primary care physician, plus blood work and whatever screenings insurance covers. A Taiwan senior screening is a full day or two with imaging (calcium score, DEXA, often abdominal ultrasound or MRI), full labs, often cognitive assessment, and a sit-down results discussion. The U.S. system fragments specialist visits across months; Taiwan compresses them into a coordinated single trip with one written report. Different tool for different jobs.
A printed list of every medication (prescription, OTC, supplement) with name, dose, frequency, indication, and prescribing physician. Recent lab results from the past year. Allergy and adverse-reaction history. Implant or pacemaker cards. Vaccination history. Health care proxy or POA documents if applicable. Comfortable shoes and layered clothing for hospital air conditioning. A lightweight notebook for noting what each physician says.
Yes. Most major Taiwan screening centers will produce a full English report (PDF) and can email it directly to your home physician with your written consent. For complex findings, a short video consultation between the Taiwan attending and your U.S. physician is sometimes possible. Bringing a brief letter from your home physician summarizing your active conditions before you travel makes this exchange much smoother.